Search

Your search keyword '"Dechet, Christopher"' showing total 267 results

Search Constraints

Start Over You searched for: Author "Dechet, Christopher" Remove constraint Author: "Dechet, Christopher"
267 results on '"Dechet, Christopher"'

Search Results

3. PD58-02 GENOTYPE-PHENOTYPE ASSOCIATIONS IN VON HIPPEL-LINDAU SYNDROME: IMPLICATIONS FOR SCREENING

4. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

5. Metastasis, Mortality, and Quality of Life for Men With NCCN High and Very High Risk Localized Prostate Cancer After Surgical and/or Combined Modality Radiotherapy

9. NEXT: A phase 2 study of nivolumab adjuvant to chemoradiation in patients (pts) with localized urothelial carcinoma.

12. Initial results of a phase 2 pilot study of radium-223 and radiotherapy in untreated hormone-naïve men with oligometastatic prostate cancer to bone.

13. Plasma proteome landscape and impact of the circulatory proteome on clinical outcomes in metastatic prostate cancer.

14. Adressen der Autoren

18. Comparing pretest video genetic education for prostate cancer patients: Do patients need assistance?

19. Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series

24. Impact of pretest video genetic education in prostate cancer patients: Do patients need us?

25. Biomarker analysis and updated clinical follow-up from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in patients with muscle-invasive bladder cancer (MIBC) undergoing cystectomy.

26. NEXT: A single-arm, phase 2, open-label study of adjuvant nivolumab after completion of chemo-radiation therapy in patients with localized muscle-invasive bladder cancer.

27. Concomitant Seminal Vesicle Invasion in pT4a Urothelial Carcinoma of the Bladder with Contiguous Prostatic Infiltration is an Adverse Prognosticator for Cancer-Specific Survival after Radical Cystectomy

31. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

32. MP61-17 CHARACTERIZING CHANGES IN MUSCLE MASS AFTER RADICAL NEPHRECTOMY FOR STAGE II-IV CLEAR CELL RENAL CELL CARCINOMA

41. Contributors

47. A phase Ib/II trial of perioperative intratumoral MVA-BN-brachyury (MVA) plus systemic PROSTVAC and atezolizumab (Atezo) for intermediate-risk and high-risk localized prostate cancer (AtezoVax).

48. NEXT: A phase II, open-label study of nivolumab adjuvant to chemoradiation in patients (pts) with localized muscle invasive bladder cancer.

49. Results from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in muscle invasive bladder cancer (MIBC) undergoing cystectomy.

Catalog

Books, media, physical & digital resources